Lenvatinib is an anti-cancer medication for the treatment of certain kinds of thyroid cancer and for other cancers as well. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.

Lenvatinib can be used to treat a variety of cancers, including thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma.